Astellas just forged a licensing deal with Affinivax to develop a pneumococcal vaccine. Their target? Pfizer’s Prevnar 13—the world’s best-selling vaccine.

ASLAN just rolled out positive top-line phase 2 data for its lead drug candidate varlitinib when combined with chemotherapy for the treatment of HER2-positive…

WuXi AppTec subsidiary STA has bulked up with a new pilot plant and a fresh batch of R&D scientists trained at the company’s Shanghai R&D site.

Sun Pharma has snapped up Ocular Technologies from Auven Therapeutics, adding to its growing eyecare medicines pipeline.

Daiichi Sankyo licenses two abuse-deterrent painkillers from Inspirion to further its pain-management ambitions.

China's FDA says reports that 83% of trials have fabricated results are incorrect, but the numbers suggest the country still has a big data-integrity…

Daiichi Sankyo's ambition to build a pipeline of new oncology drugs may have just taken another big hit.

Biosimilar developers are queueing up to file copycat versions of AbbVie's Humira, the world's best-selling drug, and now, another candidate has late…

Celltrion has new data in hand from a Phase III trial of its Rituxan biosimilar CT-P10, putting it in pole position to grab a piece of the brand's $7.39…

R&D